DDIT3 and cancer: As a consequence, cancer cells certainly share higher expression of PERK and its main downstream effectors including phosphorylated eukaryotic translation initiation factor 2α (p-eIF2α), ATF4, CHOP and nuclear factor-like 2 (Nrf2) [29,34].